Company intelligence / Profile preview

Integrated Proteomics Applications

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

The company developed the IP2 search engine and workflow software to enable fast, scalable, GPU-based proteomics analysis for large cohorts and translational studies. The IP2 pipeline supports unbiased shotgun proteomics for high-confidence identification/quantification of proteins and PTMs. The pipeline enhanced downstream analysis of large-scale mass spectrometry datasets, and was acquired by Bruker in 2020 for integration with Bruker’s cutting-edge timsTOF mass spectrometry platforms.

Therapeutic areas: OtherNeurologyPsychiatry
Modalities: Proteomics bioinformatics platforms
Industry: Drug Discovery Services

Partnerships

The Scripps Research Institute, Yates LabBruker Life Science Mass Spectrometry

Beyond the preview

Go deeper on Integrated Proteomics Applications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrated Proteomics Applications.

Explore the full profile